$AIXI

Xiao-I Corp

No enriched coverage for $AIXI in the last 7 days.

No SEC Form 4 filings for $AIXI in the last 30 days.

Med

Xiao-I Corporation Replaces Assentsure With CHI-LLTC as Auditor After Review

Xiao-I Corporation (AIXI) announced it replaced its independent auditor, Assentsure PAC, with CHI-LLTC on April 13, 2026, following an audit committee review. The company stated the transition was routine, with no disagreements over accounting principles, financial disclosures, or audit procedures reported with the former auditor. Despite strong revenue growth and gross margins, TipRanks’ AI Analyst, Spark, rates AIXI an "Underperform" due to weak financial health and bearish technical indicators.

Xiao-I Corp. Secures $3.25 Million Convertible Note Financing From Institutional Investor

Xiao-I Corp. (AIXI) has secured a $3.25 million unsecured convertible note financing from an institutional investor, issued at a $3.0 million purchase price with 8.5 million pre-delivery shares. The 12-month note includes conversion options for the lender and allows for additional financing, indicating the company's continuous reliance on structured funding for capital needs. Spark, TipRanks' AI Analyst, rates AIXI as Underperform due to weak financial health despite strong revenue growth, with technicals also signaling a bearish outlook.

Xiao-I Corp. ADR Delays 2025 Annual Filing

Xiao-I Corp. ADR has announced a delay in filing its 2025 Form 20-F (Yearly Report) due to an inability to finalize financial statements and related disclosures by the original deadline. The company anticipates higher operating expenses and continued liquidity pressures, despite working to submit the report within the 15-day SEC extension. Spark, TipRanks’ AI Analyst, rates AIXI as Underperform due to weak financial health and bearish technicals.